These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26871198)

  • 21. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
    Scherer J; Dobmeier P; Kuhn K; Schmaus W
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S167-9. PubMed ID: 15570542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
    Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
    Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
    Haas M; Karcher K; Pandina GJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.
    Nishimura K; Tsuka M; Horikawa N
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New for old? Risperidone long-acting injection in older patients.
    Hudson-Jessop P; Hughes B; Brinkley N
    Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone induced rabbit syndrome.
    Rebello P; Rao PP; Nayak P; Mascarenhas JJ; Mathai PJ
    Neurol India; 2018; 66(Supplement):S150-S152. PubMed ID: 29503342
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms.
    Sanderson DR
    J Clin Psychiatry; 1996 Apr; 57(4):177. PubMed ID: 8601557
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of prescription practices of long acting injectable risperidone in French hospitals].
    Bret P; Heil M; Queuille E; Bret MC;
    Encephale; 2011 May; 37 Suppl 1():S58-65. PubMed ID: 21600335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of risperidone on balance control in young healthy individuals.
    Corbeil P; Rodrigue J; Simoneau M; Cohen H; Pourcher E
    Psychopharmacology (Berl); 2012 Jul; 222(1):59-69. PubMed ID: 22234381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meige's syndrome associated with risperidone therapy.
    Ananth J; Burgoyne K; Aquino S
    Am J Psychiatry; 2000 Jan; 157(1):149. PubMed ID: 10618045
    [No Abstract]   [Full Text] [Related]  

  • 33. Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
    Tchan MC; Sillence D
    J Intellect Dev Disabil; 2009 Sep; 34(3):275-9. PubMed ID: 19681008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 36. Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study.
    Bo QJ; Li XB; Wang ZM; Li AN; Ma X; Wang CY
    J Clin Psychopharmacol; 2016 Apr; 36(2):125-9. PubMed ID: 26848792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
    Keshen A; Carandang C
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):867-70. PubMed ID: 18315457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.